Report me for selling fake medicine? Why are you crying when your illness relapses?

When she thought of the expressions of Gao Tianlong and the others, Luo Shiyun inexplicably felt a little funny and suddenly understood their feelings.

However, although she was shocked, after careful consideration, she felt that 1000 billion was not too outrageous.

As long as the specific drug for lung cancer can be successfully launched on the market, then the profit of 1000 billion yuan will not be a problem and there is every chance that it can be achieved.

However, this is only the first phase of clinical trials, and the risks are still very high, so pharmaceutical companies dare not gamble on this probability.

If it has passed clinical trials, then it is estimated that AbbVie will most likely agree to the 1000 billion yuan offer, but now it is only the first phase.

"That's good too. No one will bother me anymore in the future."

"If they can't accept a 1000 billion yuan acquisition price, there's no need for them to come to me for negotiations."

Chen Xuan didn't care at all. He felt that independently developing a specific drug for lung cancer would only bring him greater profits.

Of course, if these pharmaceutical companies insist on acquiring it, then he can sell it and just treat it as a one-time payment for a few years of profit.

But if they are not willing to give even 1000 billion, then he naturally won't consider it.

"Do you want me to spread this news?"

"Let the outside world know about AbbVie's offer, and then they won't bother you anymore."

Luo Shiyun thought for a moment and said.

Doing so can increase the popularity of the lung cancer drug and let the outside world see the strength of this drug.

Secondly, it can allow some pharmaceutical companies to see AbbVie’s bid, thus preventing them from acquiring the company at a lower price.

Even if they still want to acquire this drug formula in the future, their bid will at least not be lower than AbbVie.

"Okay, let's do as you say." Chen Xuan nodded and agreed to the idea.

Doing so will not affect him anyway, and will help him resist most pharmaceutical companies in advance, so why not do it?

"Wow, this negotiation only took 15 minutes."

"It won't delay my experiment today."

After that, Chen Xuan glanced at the wall clock again and muttered with a smile.

From the beginning to the end of his negotiations with the AbbVie delegation, the entire process took only a quarter of an hour, which was very quick.

Hearing this, Luo Shiyun couldn't help but smile.

The AbbVie delegation prepared for so long, but in the end they only managed to get a quarter of an hour.

If it were any other company, they would never treat the AbbVie delegation like this. Only Chen Xuan could do this.

The key is that he is qualified to do so, and even giants like AbbVie are obedient and have no way to disobey his rules.

……

When the AbbVie delegation came out,

The reporters who had been squatting outside for a long time immediately took action.

"Mr. Gao, are you discussing cooperation with Antai Pharmaceutical Group on a lung cancer drug today?"

"I heard that AbbVie is planning to acquire Chen Xuan's new drug patent. Is this true?"

"Mr. Gao, how much does AbbVie plan to pay for the patent? And has Mr. Chen agreed to cooperate with you?"

"Mr. Gao, did your negotiations go smoothly this time? Will the two groups become partners in the future?"

"Mr. Gao, in addition to acquiring the new drug patents, will AbbVie also consider acquiring Antai Pharmaceutical Group?"

Various problems are basically related to new drug patents.

Everyone knows that the reason why the AbbVie delegation came to negotiate in person was for the patent of the lung cancer drug.

This is also what attracts the public's attention the most, and everyone comes here for this matter.

Especially since Changfeng Group came last time and was rejected by Chen Xuan without hesitation, the heat of this matter has become extremely high.

Now, the international giant AbbVie has also taken action personally, which makes them even more interested.

Will the wealthy AbbVie have a different outcome from Changfeng Group?

"I'm sorry, this is a commercial secret. I can't comment."